Back to EYPT

EyePoint Pharmaceuticals, Inc. 10-Q

Accession 0001193125-16-455089

Filing information

CIK
0001314102
Report date
2015-12-31
Filing date
2016-02-09
Form
10-Q
Primary document
d120199d10q.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.